Boston scientific received information that the patient with this cardiac resynchronization therapy defibrillator (crt-d) had atrial fibrillation (af) and felt something in the chest.Additional information was obtained indicating that the patient was experiencing shortness of breath following crt-d implant.A transthoracic echocardiogram was performed in which it showed a mild to moderate pericardial effusion with tamponade.In addition, patient chest x-ray result demonstrated pulmonary congestion and small pleural effusions.Moreover, the patient's breathlessness had improved with diuresis and patient was close to baseline level of dyspnea.The patient remained hemodynamically stable.Further, the patient symptoms were not device related as it was due to volume overload.This crt-d remains in service.No additional adverse patient effects were reported.
|